These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3596049)

  • 1. Immunotherapy of cancer patients with BCG: summary of ten years experience in Japan.
    Torisu M; Iwasaki K; Sakata M
    Dev Biol Stand; 1986; 58 ( Pt A)():451-6. PubMed ID: 3596049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of cancer patients with Bacillus Calmette-Guérin: summary of four years of experience in Japan.
    Torisu M; Fukawa M; Nishimura M; Harasaki H; Kai S; Tanaka J
    Ann N Y Acad Sci; 1976; 277(00):160-86. PubMed ID: 1069547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
    Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
    Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
    Margel D; Tal R; Golan S; Kedar D; Engelstein D; Baniel J
    Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of lung cancer patients treated with BCG and/or a soluble BCG fraction (F70) after surgery, radiotherapy and chemotherapy.
    Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P; Madźarova S; Spassova M
    Neoplasma; 1980; 27(1):83-94. PubMed ID: 7374861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
    Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?
    Lamm DL
    Cancer Surv; 1998; 31():99-108. PubMed ID: 15281319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible applications of living BCG and the BCG cell wall in immunotherapy].
    Canti GF; Franco P; Ricci L
    Boll Ist Sieroter Milan; 1983 May; 62(2):125-9. PubMed ID: 6626318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
    Järvinen R; Kaasinen E; Sankila A; Rintala E;
    Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant BCG immunotherapy for breast cancer (T1N0M0, T2N0M0)].
    Sakurai T; Okada K; Yokoi H; Maebeya S; Juri M; Takimoto M; Nishimura O; Okada N
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1838-42. PubMed ID: 6476845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local BCG-immunotherapy in bladder cancer patients. Immunological follow-up studies.
    Seyfarth M; Hudemann B; Nizze H; Riedel H; Werner H
    Arch Geschwulstforsch; 1982; 52(1):63-6. PubMed ID: 7082133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
    Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT
    Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cohort of long-term survivors at the German childhood cancer registry.
    Debling D; Spix C; Blettner M; Michaelis J; Kaatsch P
    Klin Padiatr; 2008; 220(6):371-7. PubMed ID: 18949673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term experience with prophylactic BCG therapy of high risk patients with superficial bladder tumors].
    Prekopp G; Kiss T
    Orv Hetil; 1997 Mar; 138(9):531-5. PubMed ID: 9102628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term remission in acute lymphoid leukemia patients on maintenance chemoimmunotherapy.
    Eremeev VS; Rumyantsev AG; Akimova GV; Osipov SG; Kislyak NS; Bergolz VM
    Neoplasma; 1981; 28(2):219-21. PubMed ID: 6942239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy.
    Joudi FN; Smith BJ; O'Donnell MA; Konety BR
    J Urol; 2006 May; 175(5):1634-9; discussion 1639-40. PubMed ID: 16600718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.